PH13858A - Stabilized thymosin fraction 5 and method for preparing same - Google Patents

Stabilized thymosin fraction 5 and method for preparing same

Info

Publication number
PH13858A
PH13858A PH20803A PH20803A PH13858A PH 13858 A PH13858 A PH 13858A PH 20803 A PH20803 A PH 20803A PH 20803 A PH20803 A PH 20803A PH 13858 A PH13858 A PH 13858A
Authority
PH
Philippines
Prior art keywords
thymosin fraction
preparing same
stabilized
reconstitution
permeate
Prior art date
Application number
PH20803A
Other languages
English (en)
Inventor
H Newmark
W Mcgregor
A Ramel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH13858A publication Critical patent/PH13858A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
PH20803A 1977-02-22 1978-02-21 Stabilized thymosin fraction 5 and method for preparing same PH13858A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/770,480 US4082737A (en) 1977-02-22 1977-02-22 Stabilized thymosin composition and method

Publications (1)

Publication Number Publication Date
PH13858A true PH13858A (en) 1980-10-22

Family

ID=25088687

Family Applications (1)

Application Number Title Priority Date Filing Date
PH20803A PH13858A (en) 1977-02-22 1978-02-21 Stabilized thymosin fraction 5 and method for preparing same

Country Status (20)

Country Link
US (1) US4082737A (de)
JP (1) JPS53104719A (de)
AT (1) AT363177B (de)
AU (1) AU516946B2 (de)
BE (1) BE864139A (de)
CA (1) CA1099633A (de)
CH (1) CH632164A5 (de)
DE (1) DE2807202C2 (de)
DK (1) DK78378A (de)
FR (1) FR2380782A1 (de)
GB (1) GB1546027A (de)
IE (1) IE46409B1 (de)
IL (1) IL54063A0 (de)
IT (1) IT1092337B (de)
LU (1) LU79090A1 (de)
NL (1) NL189281C (de)
NZ (1) NZ186489A (de)
PH (1) PH13858A (de)
SE (1) SE444647B (de)
ZA (1) ZA78890B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732587A1 (de) * 1976-09-22 1978-03-23 Bach Jean Francois Polypeptid mit thymischer wirksamkeit
US4148788A (en) * 1978-01-23 1979-04-10 Hoffmann-La Roche Inc. Synthesis of thymosin α1
US4239498A (en) * 1978-11-27 1980-12-16 Rule Allyn H Method of preparing thymic factors and composition
US4264571A (en) * 1979-01-22 1981-04-28 George Washington University Radioimmunoassay of thymosin α1
EP0057702A1 (de) * 1980-08-08 1982-08-18 Rak-A-Van Pty Limited Verbessertes regal
US4427783A (en) 1981-12-14 1984-01-24 Hoffmann-La Roche Inc. Immunoassay of thymosin α1
US4389343A (en) * 1981-12-24 1983-06-21 Hoffmann-La Roche Inc. Immunopotentiating peptides from thymus
US4388234A (en) * 1981-12-28 1983-06-14 Hoffmann-La Roche Inc. Peptide isolation
US4614731A (en) * 1983-09-15 1986-09-30 Hoffmann-La Roche Inc. Peptide having immunopotentiating activity similar to thymosin alpha1
US4659694A (en) * 1983-10-27 1987-04-21 Hoffmann-La Roche Inc. Prothymosin alpha
US4814434A (en) * 1984-02-03 1989-03-21 Ventres Laboratories, Inc. Inducer of T-suppressor cells
DE3633651A1 (de) * 1986-10-03 1988-04-14 Alfred Dr Dick Verwendung von fraktionen aus thymus- und milzextrakten zur behandlung der psoriasis
US5273963A (en) * 1991-03-29 1993-12-28 The George Washington University Compositions and methods for treating small cell and nonsmall cell lung cancers
JP4404866B2 (ja) 2006-03-03 2010-01-27 ゼライス株式会社 エンドトキシン含有量を低減したゼラチンの製造方法および低エンドトキシンゼラチン

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002602A (en) * 1974-03-11 1977-01-11 Gideon Goldstein Ubiquitous immunopoietic polypeptide (UBIP) and methods
US4010148A (en) * 1975-05-12 1977-03-01 Board Of Regents Of The University Of Texas System Purified thymosin and process
US4002740A (en) * 1975-08-21 1977-01-11 Gideon Goldstein Tridecapeptide compositions and methods

Also Published As

Publication number Publication date
NL7801422A (nl) 1978-08-24
FR2380782B1 (de) 1980-01-18
IT1092337B (it) 1985-07-06
NZ186489A (en) 1981-01-23
IE780335L (en) 1978-08-22
FR2380782A1 (fr) 1978-09-15
IL54063A0 (en) 1978-04-30
BE864139A (fr) 1978-08-21
DE2807202A1 (de) 1978-08-24
SE444647B (sv) 1986-04-28
AU516946B2 (en) 1981-07-02
AU3334378A (en) 1979-08-23
ATA124578A (de) 1980-12-15
IT7819791A0 (it) 1978-01-30
IE46409B1 (en) 1983-06-01
US4082737A (en) 1978-04-04
NL189281C (nl) 1993-03-01
AT363177B (de) 1981-07-10
GB1546027A (en) 1979-05-16
JPS618806B2 (de) 1986-03-18
JPS53104719A (en) 1978-09-12
LU79090A1 (fr) 1979-05-25
ZA78890B (en) 1979-01-31
DE2807202C2 (de) 1987-04-02
NL189281B (nl) 1992-10-01
SE7802014L (sv) 1978-08-23
CA1099633A (en) 1981-04-21
DK78378A (da) 1978-08-23
CH632164A5 (de) 1982-09-30

Similar Documents

Publication Publication Date Title
FR2380782B1 (de)
FI820116A7 (fi) Jauhemainen polymeerikoostumus, menetelmä sen valmistamiseksi ja sen käyttö.
SE8402560D0 (sv) Farmaceutisk komposition
IT8422580A0 (it) Composizioni che le contengono e proteine di membrana cellulare, procedimento per prepararle.
FI843716A7 (fi) Pyridiiniliukoista uutetta ja puhdistettua, myrkyttömäksi tehtyä endotoksiinia sisältävä koostumus ja sen käyttö.
FI813862A7 (fi) Uusia 8-aryylialkyyli-3- fenyyli-3- nortropanoleja, niiden happoadditiosuoloja, näitä sisältäviä lääkeainelääkeaineita ja menetelmiä niiden valmistamiseksi.
AR240450A1 (es) Excluida su aplicacion en o sobre animales, derivados de acido oxamidico, procedimiento para su preparacion y composiciones parasiticidas que los contienen.
FI830163A7 (fi) Fenyylietyleeni-johdannaisia, niiden valmistus ja käyttö lääkeaineina.
IT8548093A0 (it) Eteri amminociclopentilici, procedimento per prepararli e composizione farmaceutica che li comprende
IT1131736B (it) Inserto elastico per sedili in particolare per poltrone di autoveicoli
SE413171B (sv) Fergkompositioner for keratinfibrer, i synnerhet for menniskohar, innehallande 3-halogen-6-acetylamino (eller ureido) fenol-kopplingssubstanser
ES1007905Y (es) Depresor lingual para uso en pediatria.
MX168053B (es) Composicion aglutinante de formaldehido para preparar productos laminares lignocelulosicos con adhesivos basados en formaldehido y procedimiento para obtener dicha composicion
IT1177147B (it) Composizione farmaceutica per combattere infezioni virali, e procedimento di uso per le infezioni virali
IT8835737V0 (it) Poltrona perfezionata per mezzi di trasporto, in particolare per aeromobili
FI822671A7 (fi) Aminoglykosidijohdannaisia, menetelmiä niiden valmistamiseksi, niitä sisältäviä farmaseuttisia koostumuksia ssekä tällaisia johdannaisia kä ytettäviksi lääkeaineina.
FI843139A7 (fi) Menetelmä dihydrokarbyylikarbonaattien valmistamiseksi, niiden käyttö polttoaineiden lisäaineina ja niitä sisältäviä polttoaineseoksia.
NO913502L (no) Kompositt for anvendelse som hoeyenergi-sprengstoff eller drivmiddel.
IT7925308A0 (it) Metodo per la crescita di piante, particolarmente piante boschive, e unita' di crescita per l'uso in detto metodo.
IT8721055A0 (it) Derivati prostaglandinici, procedimenti per prepararli e composizioni farmaceutiche che licontengono.
IT7927018A0 (it) Procedimento per la preparazione di omega-lattami, in particolare caprolattame.
FA et al. Influence of combined effects of bleomycin and X-rays on the growth rate of eat and hela cells
IT8421310A0 (it) Meccanismo per mobili per sedersi e, rispettivamente per riposarsi.
Bovornkitti et al. Dissertation of reported cases of nontuberculous mycobacteriosis in Thailand.
LUO et al. Observation on cardiovascular function and oxygen transport during hemorrhagic shock at 4 000 m altitude in dogs

Legal Events

Date Code Title Description
AT Record of annual fee payments

Year of fee payment: 14